In the case of PFS, patients with low expression levels for NSD1 in ACC and high expression in KIRC are associated with a longer PFS, while patients with high levels of NSD2 in ACC, LIHC, LUAD, MESO, and PRAD, as well as low NSD2 expression in GBM have a poor PFS (Figure 1E and Figure S3B). The gene discussed is NSD2; the disease is glioblastoma.